LexBlog IP

AUGUST 30, 2023

market on March 7, 2025, if approved by FDA. J&J also recently filed a confidential settlement and license agreement to terminate a Samsung Bioepis challenge to all claims of U.S.

Settlement 40

Settlement Confidentiality Marketing Marketing 40

SpicyIP

APRIL 30, 2023

Nirtech – Analysing the Claim of Breach of Confidential Information Image from here. Ex-employees using confidential information acquired from the former employer! Nirtech on protecting confidential information. Other posts Rochem v. In this post, the author discusses the Bombay High Court order in Rochem v.

Confidentiality 105

Confidentiality Trademark Copyright Patent 105

The IPKat

NOVEMBER 14, 2022

a wise cat that care about environment kindly provided in CC0 Public Domain license by Pixhere.com) Having to make a selection among the many topics covered, this GuestKat finds it interesting to note that during the conference the EPO case G2/21 on 'plausibility', was repeatedly discussed from different angles.

IP 78

IP Marketing Marketing Confidentiality 78

LexBlog IP

JANUARY 16, 2023

The European Commission expressed its hope that the provisions of the regulation will enter into force across all EU member states in 2025. If approved, the EHDS proposal would introduce a new regime for the compulsory licensing of health data to third parties.

Intellectual Property 52

Intellectual Property Business Confidentiality Advertising 52

LexBlog IP

FEBRUARY 1, 2024

In October 2023, Accord settled with Janssen Biotech under confidential terms that would allow Accord to launch its proposed ustekinumab biosimilar no later than May 15, 2025, pending FDA approval.

Confidentiality 40

Confidentiality Reporting Licensing Marketing 40

Trading Secrets

NOVEMBER 12, 2024

Then, for each overlapping product or service, the FTC proposes that the filing party also provide sales, customer information (including contacts), a description of any licensing arrangement, and a description of any non-compete or non-solicitation agreements applicable to the employees or business units related to the product or service.

Reporting 40

Reporting Business Confidentiality Contracts 40

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. Legislation Relating to Biologics and Biosimilars. BPCIA Litigation. Antitrust Litigation. Post-Grant Challenges at the PTAB. Conclusion.

Settlement 52

Settlement Litigation Marketing Marketing 52

SpicyIP

DECEMBER 31, 2024

Wishing everyone a prosperous and a healthy new year ahead and hoping that 2025 brings in spicier IP developments to the Indian IP regime, making it a more fair, balanced and effective one! As always, a huge thanks to all our contributors including our readers who engage online as well as offline with our posts and constantly encourage us.

IP 105

IP Invention Patent Copyright 105